QSARs on human carbonic anhydrase VA and VB inhibitors of some new not yet synthesized, substituted aromatic/heterocyclic sulphonamides as anti-obesity agent

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 27, Issue 5, 2012, Pages 666-672

  Singh, Shalini ^a   Supuran, Claudiu T ^b  

^a BAREILLY COLLEGE   (India)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Brood; Carbonic anhydrase VA; Omega; PRECLAV; QSAR; VB

Indexed keywords

ACETAZOLAMIDE; ANTIOBESITY AGENT; SULFONAMIDE; TOPIRAMATE; ZONISAMIDE;

ARTICLE; COMPUTER PROGRAM; DRUG SYNTHESIS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANTI-OBESITY AGENTS; CALIBRATION; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASE V; HETEROCYCLIC COMPOUNDS; HUMANS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 84866091339     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.606544     Document Type: Article

References (27)

1. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-181. (Pubitemid 351194064)
2. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336-4350. (Pubitemid 46777288)
3. Supuran CT, Scozzafava A, Conway J, eds. Carbonic anhydrase-its inhibitors and activators; Boca Raton (FL): CRC Press USA; 2004. P1-376.
4. Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146-189. (Pubitemid 36241096)
5. Winum JY, Rami M, Scozzafava A, Montero JL, Supuran CT. Carbonic anhydrase IX: A new druggable target for the design of antitumor agents. Med Res Rev 2008;28:445-463. (Pubitemid 351590542)
6. Lynch CJ, Fox H, Hazen SA, Stanley BA, Dodgson S, Lanoue KF. Role of hepatic carbonic anhydrase in de novo lipogenesis. Biochem j 1995;310 (Pt 1):197-202.
7. Hazen SA, Waheed A, Sly WS, LaNoue KF, Lynch CJ. Differentiationdependent expression of CA V and the role of carbonic anhydrase isozymes in pyruvate carboxylation in adipocytes. Faseb J 1996;10: 481-490. (Pubitemid 26120323)
8. Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB. Bioorg Med Chem 2009;17:4894-4899.
9. Hebebrand J, Antel J, Preuschoff U, David S, Sann H, Weske M. Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity. WO Patent, 07821, 2002.
10. BROOD (version 2.0.0), OpenEye Science Software, 3600 Cerrillos Road, Suite 1107, Santa Fe, USA, 2010.
11. OMEGA (version 2.4.3), OpenEye Science Software, 3600 Cerrillos Road, Suite 1107, Santa Fe, USA, 2010.
12. Tresadern G, Bemporad D, Howe T. A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor. J Mol Graph Model 2009;27:860-870.
13. Halgren TA. MMFF VI. MMFF94s option for energy minimization studies. J Comput Chem 1999;20:720-729. (Pubitemid 129652635)
14. Stewart JJP. Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. j Mol Model 2007;13:1173-1213. (Pubitemid 47629446)
15. Stewart JJP. MOPAC2009, Stewart Computational Chemistry, Colorado Springs, CO, USA, http://OpenMOPAC.net 2008.
16. PRECLAV V. 1011 (documentation included) is available from Center of Organic Chemistry-Bucharest, 2010.
17. Tarko L. Calculate QSPR/QSAR cu ajutorul programului PRECLAV. Rev Chim (Bucuresti) 2005; 56:639.
18. Tarko L, Lupescu I, Groposila-Constantinescu D. Sweetness power QSARs by PRECLAV software. Arkivoc 2005;x:255.
19. Tarko L, Stecoza CE, Ilie C, Chifiriuc MC. QSAR Studies on antibacterial activity of some substituted dihydrodibenzothiepins. Rev Chim (Bucuresti) 2009;60:476.
20. Tarko L. QSAR studies regarding the inhibition of the carbonic anhydrase by the sulfonamides containing a picolinoyl group. Rev Chim (Bucuresti) 2007; 58:192.
21. Tarko L, Avram S, Mihailescu D. Prediction for antidepressants activity using QSAR Study. Rev Chim (Bucuresti), 2011; 62:371.
22. Done R, Mandrila G, Tarko L. QSAR study concerning toxicity and threshold limit value VL8 of chlorine containing compounds. Rev Chim (Bucuresti) 2009;60:214.
23. Singh Shalini, Khadikar PV, Scozzafava A, Supuran CT. QSAR studies for the inhibition of the trans membrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software. J Enzyme Inhib Med Chem 2009;24:337-349.
24. Singh S. Comparative QSAR studies on the novel series of thiazolones and tetrazole derivatives as HCV NS5B polymerase allosteric inhibitors. Lett Drug Des Discov 2009;6:286-297.
25. Singh Shalini, Singh Sarika, Shukla Poonam. Modeling of novel HIV-1 protease inhibitors incorporating N-Aryl-oxazolidinone-5-carboxamides as P2 ligands using quantum chemical and topological finger print descriptors. Med Chem Res 2010;DOI 10.1007/s00044-010-9416-0.
26. Tarko L. Fragmentarea virtual a moleculelor si evaluarea similaritatilor. Rev Chim (Bucuresti) 2004;55:539.
27. Tarko L. A procedure for virtual fragmentation of molecules into functional groups. ARKIVOC 2004;xiv:74